Purushothaman and Toole [16] on the other hand observed that the xenografted tumors formed by a multiple myeloma cell line where serglycin had been knocked-down grew smaller than those expressing high levels of serglycin, although proliferation of these cells was unaffected by serglycin expression in vitro. Here, SRGN is linked to plasma cell myeloma.